420 related articles for article (PubMed ID: 35573838)
21. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein.
Martinez-Valbuena I; Valenti-Azcarate R; Amat-Villegas I; Marcilla I; Marti-Andres G; Caballero MC; Riverol M; Tuñon MT; Fraser PE; Luquin MR
Acta Neuropathol Commun; 2021 Apr; 9(1):64. PubMed ID: 33832546
[TBL] [Abstract][Full Text] [Related]
22. Tunneling nanotubes: A possible highway in the spreading of tau and other prion-like proteins in neurodegenerative diseases.
Abounit S; Wu JW; Duff K; Victoria GS; Zurzolo C
Prion; 2016 Sep; 10(5):344-351. PubMed ID: 27715442
[TBL] [Abstract][Full Text] [Related]
23. Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds.
Holmes BB; DeVos SL; Kfoury N; Li M; Jacks R; Yanamandra K; Ouidja MO; Brodsky FM; Marasa J; Bagchi DP; Kotzbauer PT; Miller TM; Papy-Garcia D; Diamond MI
Proc Natl Acad Sci U S A; 2013 Aug; 110(33):E3138-47. PubMed ID: 23898162
[TBL] [Abstract][Full Text] [Related]
24. Diverse Misfolded Conformational Strains and Cross-seeding of Misfolded Proteins Implicated in Neurodegenerative Diseases.
Lim KH
Front Mol Neurosci; 2019; 12():158. PubMed ID: 31338019
[TBL] [Abstract][Full Text] [Related]
25. α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects.
Daniele S; Pietrobono D; Fusi J; Iofrida C; Chico L; Petrozzi L; Gerfo AL; Baldacci F; Galetta F; Siciliano G; Bonuccelli U; Santoro G; Trincavelli ML; Franzoni F; Martini C
Mol Neurobiol; 2018 Mar; 55(3):2653-2675. PubMed ID: 28421539
[TBL] [Abstract][Full Text] [Related]
26. Spreading of Alzheimer tau seeds is enhanced by aging and template matching with limited impact of amyloid-β.
Nies SH; Takahashi H; Herber CS; Huttner A; Chase A; Strittmatter SM
J Biol Chem; 2021 Oct; 297(4):101159. PubMed ID: 34480901
[TBL] [Abstract][Full Text] [Related]
27. On the role of the cellular prion protein in the uptake and signaling of pathological aggregates in neurodegenerative diseases.
Legname G; Scialò C
Prion; 2020 Dec; 14(1):257-270. PubMed ID: 33345731
[TBL] [Abstract][Full Text] [Related]
28. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
Yoshida K; Higuchi K; Ikeda S
Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
[TBL] [Abstract][Full Text] [Related]
29. The role of the cellular prion protein in the uptake and toxic signaling of pathological neurodegenerative aggregates.
Scialò C; Legname G
Prog Mol Biol Transl Sci; 2020; 175():297-323. PubMed ID: 32958237
[TBL] [Abstract][Full Text] [Related]
30. Prion-like features of misfolded Aβ and tau aggregates.
Morales R; Callegari K; Soto C
Virus Res; 2015 Sep; 207():106-12. PubMed ID: 25575736
[TBL] [Abstract][Full Text] [Related]
31. Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases.
Melki R
J Parkinsons Dis; 2015; 5(2):217-27. PubMed ID: 25757830
[TBL] [Abstract][Full Text] [Related]
32. The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model.
Yuste-Checa P; Trinkaus VA; Riera-Tur I; Imamoglu R; Schaller TF; Wang H; Dudanova I; Hipp MS; Bracher A; Hartl FU
Nat Commun; 2021 Aug; 12(1):4863. PubMed ID: 34381050
[TBL] [Abstract][Full Text] [Related]
33. Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates.
Rostami J; Mothes T; Kolahdouzan M; Eriksson O; Moslem M; Bergström J; Ingelsson M; O'Callaghan P; Healy LM; Falk A; Erlandsson A
J Neuroinflammation; 2021 Jun; 18(1):124. PubMed ID: 34082772
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of Pathogenic Tau and Aβ Protein Spreading in Alzheimer's Disease.
d'Errico P; Meyer-Luehmann M
Front Aging Neurosci; 2020; 12():265. PubMed ID: 33061903
[TBL] [Abstract][Full Text] [Related]
35. The role of heparan sulfates in protein aggregation and their potential impact on neurodegeneration.
Maïza A; Chantepie S; Vera C; Fifre A; Huynh MB; Stettler O; Ouidja MO; Papy-Garcia D
FEBS Lett; 2018 Dec; 592(23):3806-3818. PubMed ID: 29729013
[TBL] [Abstract][Full Text] [Related]
36. Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases.
Sengupta U; Kayed R
Prog Neurobiol; 2022 Jul; 214():102270. PubMed ID: 35447272
[TBL] [Abstract][Full Text] [Related]
37. Alpha-synuclein spreading in Parkinson's disease.
Recasens A; Dehay B
Front Neuroanat; 2014; 8():159. PubMed ID: 25565982
[TBL] [Abstract][Full Text] [Related]
38. Spatially-extended nucleation-aggregation-fragmentation models for the dynamics of prion-like neurodegenerative protein-spreading in the brain and its connectome.
Fornari S; Schäfer A; Kuhl E; Goriely A
J Theor Biol; 2020 Feb; 486():110102. PubMed ID: 31809717
[TBL] [Abstract][Full Text] [Related]
39. Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies.
Annadurai N; De Sanctis JB; Hajdúch M; Das V
Exp Neurol; 2021 Sep; 343():113756. PubMed ID: 33989658
[TBL] [Abstract][Full Text] [Related]
40. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
